Personalized Medicine

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

Massachusetts General Hospital (Mass General) is a world-renowned academic medical center and the original and largest teaching hospital of Harvard Medical School. Mass General is recognized for its commitment to high-quality patient care, innovative research, and comprehensive educational opportunities. The hospital operates the largest hospital-based research program in the United States, fostering collaboration among leading clinicians and scientists to bridge innovation science with state-of-the-art clinical medicine. Mass General for Children (MGfC) is a leader in pediatric care, offering more than 50 medical specialties and 15 surgical services, and is home to the only proton beam facility in New England. The hospital is dedicated to serving local and global communities, training the next generation of healthcare professionals, and advancing medical knowledge through groundbreaking research, multidisciplinary care, and a strong commitment to family-centered and equitable healthcare.

Danforth Advisors is a strategic and operational consulting firm dedicated to supporting life science companies. They provide a comprehensive range of services tailored to the unique needs of biotech and pharmaceutical companies, from operational finance and accounting to clinical development and regulatory affairs. Their mission is to empower clients with expert guidance and flexible solutions that advance scientific innovation and drive business success.

CRI Genetics, part of the Cellular Research Institute, aims to unlock complex genetic information and present it in an engaging and useful manner. Their mission is to enhance human life and advance the understanding of the human genome through consumer genetic reports and active participation in scientific research. They believe genetic analysis is the future of medicine and are committed to solving complex medical problems. The company ensures the privacy and security of customer data, offering an 8-week efficiency guarantee for delivering genetic reports.

The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) charitable organization dedicated to advancing the rapid deployment of innovative medical technologies that improve the health of both military personnel and civilians. MTEC fosters military-civilian partnerships and collaboration among businesses, federal agencies, academic institutions, and other stakeholders. Through a flexible Other Transaction Agreement (OTA), MTEC expedites the development and commercialization of cutting-edge medical solutions, bridging the gap between research and real-world application. With over 700 members, MTEC has facilitated more than $1.3 billion in federal funding, 358 awarded projects, and a robust pipeline of 141 products.

Xtory is a Harvard spin-off that combines AI and 3D technology to revolutionize healthcare and education. The company aims to provide trustworthy medical information and decision-making tools to improve patient outcomes and streamline clinical workflows. With a focus on innovation and scientific rigor, Xtory is dedicated to reshaping healthcare through AI-driven solutions.

Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Ultimaxx Health is a pioneering company dedicated to developing innovative plant-based medicines and natural solutions to address pressing public health issues, chronic conditions, and general health and wellness. With a mission to change the world naturally, Ultimaxx Health focuses on creating non-narcotic, non-habit forming alternatives to prescription painkillers, aiming to improve the general health and well-being of humanity. The company leverages advanced science and technology, including digital health technologies, AI, and data analytics, to promote healthy aging and optimize consumer health through personalized, data-driven approaches.

Booz Allen Hamilton is a leading management and technology consulting firm with over 110 years of experience. The company is dedicated to empowering people to change the world through innovative solutions in various sectors including cybersecurity, artificial intelligence, engineering, and defense. Booz Allen partners with government and commercial clients to tackle their most complex challenges, leveraging a culture of innovation and a commitment to excellence. The firm operates with core values of integrity, courage, service, ingenuity, and a commitment to diversity and inclusion.

XO Armor Technologies specializes in custom protective solutions using advanced 3D scanning and printing technology. Their mission is to enhance safety and performance for athletes, patients, and first responders by providing personalized protective gear that meets individual needs. The company is dedicated to revolutionizing patient care and sports medicine through innovative technology and a commitment to quality.

DLH delivers improved health and national security readiness solutions for federal programs through science research and development, systems engineering and integration, and digital transformation. With over 3,200 employees, DLH is committed to solving complex problems faced by civilian and military customers, leveraging advanced technologies and methodologies to enhance health outcomes and operational readiness.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

EuMentis Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies for serious neuropsychiatric conditions. The company integrates clinically validated science with cutting-edge technology to create effective treatments for conditions like Tourette syndrome and autism spectrum disorder, focusing on restoring balance in neurotransmitter systems.

Gladstone Institutes is an independent biomedical research organization dedicated to tackling the biggest challenges in human health. By disrupting traditional scientific methods, Gladstone aims to make groundbreaking discoveries that can transform lives. The organization is renowned for its innovative approaches in research, focusing on conditions with significant medical, economic, and social impacts. Founded in 1979 from a donation by J. David Gladstone, the institute has expanded its research areas to include cardiovascular, neurological, and viral diseases, as well as data science and biotechnology.